FYN and Alzheimer disease: Fyn distribution and levels are altered in AD brains [220,221], and the genetic ablation of Fyn counteracts Aβ oligomers toxicity in hippocampal slices [222], suggesting that Aβ may derange synaptic functions through the aberrant activation of Fyn-related pathways [13,223].